| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 07/31/2003 | WO2003006016A3 Use of nk-1 receptor antagonists with pyridinic structure, for the treatment of brain, spinal or nerve injury |
| 07/31/2003 | WO2002060875A8 Nicotinamide biaryl derivatives useful as inhibitors of pde4 isozymes |
| 07/31/2003 | WO2002040471A9 Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents) |
| 07/31/2003 | US20030144522 Substituted N-aryl nitrogen-containing heterocyclic compounds |
| 07/31/2003 | US20030144512 Process for preparing piperazinepentaneamide HIV protease inhibitors |
| 07/31/2003 | US20030144506 Formula 1 are useful in treating abnormal cell growth in mammals by administering pharmaceutical compositions. |
| 07/31/2003 | US20030144332 Diarylcycloalkyl derivatives, processes for their preparation and their use s pharmaceuticals |
| 07/31/2003 | US20030144330 Peroxidase proliferator activated receptor (PPAR) gamma agonists for playing key role in inducing growth arrest by terminal differentiation of actively proliferating PPAR gamma-expressing cells, particularly transformed adipose cells |
| 07/31/2003 | US20030144328 Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 07/31/2003 | US20030144326 Cyclic amine phenyl beta-3 adrenergic receptor agonists |
| 07/31/2003 | US20030144320 For treatment and/or prevention of anxiety, mania, depression, panic disorders, nerve sustem disorders |
| 07/31/2003 | US20030144308 Fructose 1,6-bisphosphatase inhibitors |
| 07/31/2003 | US20030144289 Dopamine and serotonin reuptake antagonists, used for the prophylaxis of drug abuse or dependence, neurodegenerative diseases or as antidepressants |
| 07/31/2003 | US20030144287 Heterocyclic amides such as N-(4-(2-(((methyl)amino)methyl)-1H-imidazol-1-yl)-2-fluorophenyl)-1-(3-amino-1,2-benzisoxazol-5-yl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide, used as anticoagulants; prophylaxis of cardiovascular disorders |
| 07/31/2003 | US20030144282 Inhibitors of cytosolic phospholipase A2 |
| 07/31/2003 | US20030144281 Substituted benzimidazole compounds |
| 07/31/2003 | US20030144280 Heterocyclic imines, used as cyclooxygenase inhibitors, administered as inflammatory and pain relievers in disorders such as arthritis, neurodegeneration or cancer in mammals |
| 07/31/2003 | US20030144277 Piperizinones as modulators of chemokine receptor activity |
| 07/31/2003 | US20030144276 Heterocycle-containing carboxylic acid derivative and drug containing the same |
| 07/31/2003 | US20030144263 Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them |
| 07/31/2003 | US20030144175 Protease inhibitors |
| 07/31/2003 | CA2473796A1 Substituted quinazolin-4-ylamine analogues |
| 07/31/2003 | CA2473510A1 Pyrimidine derivatives as rho-kinase inhibitors |
| 07/31/2003 | CA2472682A1 Treating stress response with chemokine receptor ccr5 modulators |
| 07/31/2003 | CA2472239A1 3-(imidazolyl)-2-aminopropanoic acids for use as tafi-a inhibitors for the treatment of thrombotic diseases |
| 07/30/2003 | EP1331224A1 Thiazole or oxazole derivatives |
| 07/30/2003 | EP1330460A2 Benzoxazinone derivatives, their preparation and use |
| 07/30/2003 | EP1330454A1 Benzopyranyl heterocycle derivatives, process for preparation thereof, and pharmaceutical compositions containing them |
| 07/30/2003 | EP1330453A1 Indolylpiperidine derivatives as antihistaminic and antiallergic agents |
| 07/30/2003 | EP1330448A2 1,3-bis-(substituted-phenyl)-2-propen-1-ones and their use to treat vcam-1 mediated disorders |
| 07/30/2003 | EP1330443A1 Substituted phenyluracils |
| 07/30/2003 | EP1330442A1 Phthalazinone derivatives |
| 07/30/2003 | EP1330432A2 Substituted alkanoic acids |
| 07/30/2003 | EP1181288B1 Bicyclic oxazolidinones as antibacterial agent |
| 07/30/2003 | EP0958296B1 Heterocyclic compounds process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases |
| 07/30/2003 | EP0946541B1 Quinolines and their therapeutic use |
| 07/30/2003 | EP0835252B1 Triazole antifungal agents |
| 07/30/2003 | EP0828736B1 Substituted sulfonylphenylheterocycles as cyclooxygenase-2 and 5-lipoxygenase inhibitors |
| 07/30/2003 | CN1433421A Chemical process and intermediate |
| 07/30/2003 | CN1433414A Benzazole derivatives and their use as JNK modulators |
| 07/30/2003 | CN1433413A Novel oxazolidinone derivatives and process for the preparation thereof |
| 07/30/2003 | CN1433411A Chemical compounds |
| 07/30/2003 | CN1433402A Cycloamine CCR5 receptor antagonists |
| 07/30/2003 | CN1116288C Urea derivatives as inhibitors of inosine-5'-phospho-dehydrogenase |
| 07/30/2003 | CN1116287C Diphenyl heterocycles as potassium channel modulators |
| 07/29/2003 | US6599926 Anticoagulant agents for treatment and prevention of thromboembolic disorders |
| 07/29/2003 | US6599918 Substituted (aminoiminomethyl or aminomethyl) dihydrobenzofurans and benzopyrans |
| 07/29/2003 | US6599911 Arylsulfonic acid salts of pyrimidine-based antiviral agents |
| 07/29/2003 | US6599902 For treating or preventing a protein kinase related disorder |
| 07/29/2003 | CA2066332C Substituted 3-(pyridinylamino)-indoles and benzo¬b|thiophenes, a process for their preparation and their use as medicaments |
| 07/29/2003 | CA2048959C 3-(1,2-benzisoxazol-3-yl)-4-pyridinamines and derivatives |
| 07/24/2003 | WO2003059907A1 Nitrogenous heterocyclic compounds, process for preparation of the same and use thereof |
| 07/24/2003 | WO2003059903A2 Substituted 4-aminopyridine derivatives used as pest control agents |
| 07/24/2003 | WO2003059894A1 Novel antibacterial compounds:process for their preparation and pharmaceutical compositions containing them. |
| 07/24/2003 | WO2003059893A1 N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases |
| 07/24/2003 | WO2003059887A1 Substituted pyrazolines for use as pesticides |
| 07/24/2003 | WO2003059884A1 Modulators of lxr |
| 07/24/2003 | WO2003059269A2 Acridone inhibitors of impdh enzyme |
| 07/24/2003 | WO2003059265A2 Compositions and methods for treating heart failure |
| 07/24/2003 | WO2003059258A2 Compositions and methods for treating heart failure |
| 07/24/2003 | WO2003047577A3 Pharmaceutical compositions comprising dihydropyridinone compounds and an immunoregulatory or an antiinflammatory agent and their uses |
| 07/24/2003 | US20030139460 Antitumor, anticancer agents; antiinflammatory agents; psoriasis; antiarthritic agents; side effect reduction |
| 07/24/2003 | US20030139425 Piperazine derivatives and their use as anti-inflammatory agents |
| 07/24/2003 | US20030139413 Novel 1,3-dihydro-2h-indol-2-one derivatives, preparation method and pharmaceutical composition containing them |
| 07/24/2003 | US20030139407 Efficient synthesis of 5-heteroatom-containing -pyrazoles |
| 07/24/2003 | US20030139406 Antiinflammatory agents; antidepressants; respiratory system disorders; cognition activators |
| 07/24/2003 | US20030139405 6-Membered heterocyclic compounds useful for selective inhibition of the coagulation cascade |
| 07/24/2003 | US20030139404 N-monoacylated derivatives of o-phenylenediamines, their analogs and their use as pharmaceutical agents |
| 07/24/2003 | US20030139402 Antiinflammatory agents; Alzheimer's disease; cardiovascular disorders |
| 07/24/2003 | US20030139398 Quinazoline and quinazoline-like compounds for the treatment of integrin-mediated disorders |
| 07/24/2003 | US20030139393 Substituted homopiperidinyl benzimidazole analogues as fundic relaxants |
| 07/24/2003 | US20030139390 Compounds for the modulation of PPARgamma activity |
| 07/24/2003 | US20030139388 Antiinflammatory agents; osteoporosis |
| 07/24/2003 | US20030139379 Autoimmune disease, osteoporosis, rheumatic diseases, skin disorders |
| 07/24/2003 | US20030138664 Light emitting device material, light emitting device using thereof, and amine compound |
| 07/24/2003 | CA2472204A1 N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases |
| 07/24/2003 | CA2469435A1 Modulators of lxr |
| 07/23/2003 | EP1329457A2 Antipicornaviral compounds, their preparation and use |
| 07/23/2003 | EP1329218A1 Preventives/remedies for portal hypertension |
| 07/23/2003 | EP1328523A2 Methods for the preparation of biphenyl isoxazole sulfonamides |
| 07/23/2003 | EP1328509A1 Methods of producing oxazolidinone compounds |
| 07/23/2003 | EP1254134B1 1,3-dihydro-2h-indol-2-one derivatives,and their use as ligands for v1b or v1b and v1a arginine-vasopressin-receptors |
| 07/23/2003 | EP1187819B1 N-substituted perhydro diazine |
| 07/23/2003 | EP1120415B1 Substituted isoxazolylthiophene compounds |
| 07/23/2003 | EP1079829B1 Use of benzofuroxan derivatives in treating angina pectoris |
| 07/23/2003 | EP0929528B1 Aralkyl and aralkylidene heterocyclic lactams and imides |
| 07/23/2003 | CN1432014A Triazole compounds having amide linkage |
| 07/23/2003 | CN1432011A Benzoamide piperidine compounds as substance P antagonists |
| 07/23/2003 | CN1431995A Antipicornaviral compounds and compsns. their pharmaceutical uses, and materials for their synthesis |
| 07/23/2003 | CN1115336C 1-phenyl-benzimidazole compounds and their use as BAGA-A receptor modulator |
| 07/22/2003 | US6596903 Ring opening 4-(2-amino-1-hydroxyethyl)oxazoline by reaction with organic mercaptan; stereospecific; human immunodeficiency virus protease inhibitors |
| 07/22/2003 | US6596747 For therapy of diseases associdated with Factor VIIa and or inosine monophosphate dehydrogenase (IMPDH) |
| 07/22/2003 | US6596745 Method for treating fibrotic diseases with azolium chroman compounds |
| 07/22/2003 | US6596743 Carbamic acid derivatives |
| 07/22/2003 | US6596742 Substituted 3-phenyl-5-alkoxy-1,3,4-oxadiazol-2-ones, their preparation and their use in medicaments |
| 07/22/2003 | US6596738 Inhibiting activity to adenosine deaminase (hereinafter described as ADA) An adenosine deaminase inhibiting agent comprising a compound of the formula (I): |
| 07/22/2003 | US6596728 A pharmaceutical composition, comprising at least one compound or salt thereof as claimed in claim 1 and a polypeptides with excipients |
| 07/22/2003 | US6596724 Oxadiazole and thiadiazole derivatives of dihydropyridine NPY antagonists |
| 07/22/2003 | US6596723 Fungal efflux pump inhibitors |
| 07/22/2003 | US6596722 Serotonin reuptake inhibitors/HT3 receptor antagonists useful for treatment of depression, psychosis, anxiety disorders, panic disorder, obsessive compulsive disorder, and eating disorders |